Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03798327 · ClinicalTrials.gov registry record · NA
Palliative Care at Home for Dementia
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03798327 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 60 participants.
The verdict
NCT03798327, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The proposed project is a randomized controlled trial of a new home-based palliative care program for adults with advanced dementia and their caregivers within the Mount Sinai Health System. Potential subjects will be identified from Mount Sinai records or referred by a Mount Sinai healthcare provider. Patients will only be approached after authorization by their Mount Sinai physician. Participants who consent to enrollment will be randomized to receive the intervention (home-based palliative care program) or usual care (with their nominated Mount Sinai physician). Patients will be enrolled in the study for 6 months. Effectiveness of the intervention will be determined through assessment of patient and caregiver reported outcomes and abstraction of data from medical records and administrative claims. Impact on the following parameters will be measured: (i) Patient symptoms, quality of life, satisfaction with care, documentation of advanced directives, receipt of care consistent with preferences (ii) Caregiver burden, satisfaction with care, and depression (iii) Healthcare utilization and costs of care.
Interventions
- BEHAVIORAL Home Palliative Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-04-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03798327
The ClinicalTrials.gov registry entry for NCT03798327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home Palliative Care is the first listed.
NCT03798327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03798327 about?
NCT03798327 is a clinical study titled "Palliative Care at Home for Dementia". The proposed project is a randomized controlled trial of a new home-based palliative care program for adults with advanced dementia and their caregivers within the Mount Sinai Health System. Potential subjects will be identified from Mount Sinai records or referred by a Mount Sinai healthcare provid...
What is the current status of trial NCT03798327?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-11-01. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT03798327?
The interventions under investigation include: Home Palliative Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03798327?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.